LUMA Vision Receives FDA Clearance for VERAFEYE 2D/4D Cardiac Visualization Platform

Contributed by: PR Newswire

Images

PR Newswire associated0

Tags

LUMA-Vision

More Like This

PR Newswire associated0

LUMA Vision Successfully Completes First-in-Human Procedures with its Novel VERAFEYE™ Navigation and Visualization Platform

LUMA Vision Co-Founders, CEO Fionn Lahart (right) and Chief Technology Officer Christoph Hennersperger (left). (Photo: Business Wire)

LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform

Caldera Medical Acquires UVision360 and the LUMINELLE Product Family, Expanding Minimally Invasive Hysteroscopy Portfolio

MedLumics New CEO and Board Member Announces 10 Patients Treated in First in Man (FIM) Clinical Trial With the Real-Time Visually Guided AblaView PFA System

LumiThera Provides Update on FDA Review of Valeda Treatment for Dry AMD Patients

LumiThera Obtains FDA Authorization of Valeda Treatment for Dry AMD Patients to Improve Vision

Evolution Optiks Receives U.S. FDA 510(k) Clearance for Breakthrough Eye Examination Device

PR Newswire associated0

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers